Surgery Following EGFR TKI Therapy Shows Potential to Extend Progression-Free Survival in Metastatic NSCLC
(Barcelona, Spain, September 9, 2025, 10:15 a.m. CEST / UTC +2) — Groundbreaking findings from a randomized Phase II clinical ...
(Barcelona, Spain, September 9, 2025, 10:15 a.m. CEST / UTC +2) — Groundbreaking findings from a randomized Phase II clinical ...
In recent years, the landscape of lung cancer diagnosis and screening has witnessed a significant paradigm shift, particularly in recognizing ...
In a significant development in the field of thoracic oncology, recent findings from the Phase 3 E4512 clinical trial have ...
In a groundbreaking development presented at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine